Autopsy report · NCT03334240

ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

“Lack of effect in interim analysis”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 1 month before it stopped.
• 28 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Maruho Co., Ltd.

Sponsor type

Industry

Conditions

HPV-Induced Genital Lesions

Interventions

CLS003; Vehicle

Participants

28

Sites

1

Countries

Netherlands

Trials that died the same way

• A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility
  “Lack of efficacy determined at interim analysis” (81% match in meaning)
• Moxonidine in Patients Undergoing Vascular Surgery
  “Study was stopped after pre-definied interim analysis because of no effects” (80% match in meaning)
• The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients
  “Interim analysis provided enough data” (79% match in meaning)
• Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke
  “The interim analysis of another associated study is not very effective” (77% match in meaning)
• Conversational Hypnosis in Women Undergoing Imaging for Breast Cancer
  “Results not achievable after interim analysis conclusions and recruting difficulty” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.